Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Immunology. Regulating the regulators.

Powrie F, Maloy KJ.

Science. 2003 Feb 14;299(5609):1030-1. No abstract available.

PMID:
12586934
2.

Control of regulatory T cell development by the transcription factor Foxp3.

Hori S, Nomura T, Sakaguchi S.

Science. 2003 Feb 14;299(5609):1057-61. Epub 2003 Jan 9.

3.

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Pasare C, Medzhitov R.

Science. 2003 Feb 14;299(5609):1033-6. Epub 2003 Jan 16.

4.

Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.

Fehérvári Z, Sakaguchi S.

Int Immunol. 2004 Dec;16(12):1769-80. Epub 2004 Nov 1.

PMID:
15520045
5.

Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P, O'Gorman B, Jarnicki A, McGuirk P, Mills KH.

J Immunol. 2003 Sep 15;171(6):3119-27.

6.

Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allografts.

Cortesini NS, Colovai AI, Manavalan JS, Galluzzo S, Naiyer AJ, Liu J, Vlad G, Kim-Schulze S, Scotto L, Fan J, Cortesini R.

Transpl Immunol. 2004 Sep-Oct;13(2):73-82. Review. No abstract available.

PMID:
15380537
7.

The immunobiology of the TLR9 subfamily.

Wagner H.

Trends Immunol. 2004 Jul;25(7):381-6. Review. No abstract available.

PMID:
15207506
8.

Making and breaking tolerance.

Ohashi PS, DeFranco AL.

Curr Opin Immunol. 2002 Dec;14(6):744-59. Review.

PMID:
12413525
9.

Control of Mycobacterium tuberculosis through mammalian Toll-like receptors.

Stenger S, Modlin RL.

Curr Opin Immunol. 2002 Aug;14(4):452-7. Review.

PMID:
12088679
10.

[Innate immunity and allergic diseases].

Akira S.

Arerugi. 2002 Apr;51(4):352-6. Review. Japanese. No abstract available.

PMID:
12014025
11.

High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.

George TC, Bilsborough J, Viney JL, Norment AM.

Eur J Immunol. 2003 Feb;33(2):502-11.

12.
13.

T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner.

Boes M, Bertho N, Cerny J, Op den Brouw M, Kirchhausen T, Ploegh H.

J Immunol. 2003 Oct 15;171(8):4081-8.

14.
15.

Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.

Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA.

J Immunol. 2003 Oct 15;171(8):4320-8.

16.

Mechanisms of tolerance.

Bluestone JA.

Immunol Rev. 2011 May;241(1):5-19. doi: 10.1111/j.1600-065X.2011.01019.x. No abstract available.

PMID:
21488886
17.

Immunology. Now presenting: gammadelta T cells.

Modlin RL, Sieling PA.

Science. 2005 Jul 8;309(5732):252-3. No abstract available.

PMID:
16002604
18.

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.

Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ.

J Immunol. 2004 Mar 15;172(6):3712-8.

19.

TGF-beta: how tolerant can it be?

Wahl SM, Chen W.

Immunol Res. 2003;28(3):167-79. Review.

PMID:
14713712
20.

Toll-like receptors and activation of autoreactive B cells.

Leadbetter EA, Rifkin IR, Marshak-Rothstein A.

Curr Dir Autoimmun. 2003;6:105-22. Review. No abstract available.

PMID:
12408049

Supplemental Content

Support Center